Experimental pill sends a THIRD of patients with leukemia into complete remission in early trial
Researchers in Boston, Massachusetts, said the results of the trial were 'very encouraging'. They could seek FDA approval for the treatment by the end of this year. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2023 Category: Consumer Health News Source Type: news
Processed Red Meat Intake Linked to Increased Incidence of Blood Cancers
FRIDAY, March 24, 2023 -- Processed red meat intake is associated with an increased incidence of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in a Japanese population, according to a study published online March 7 in Environmental... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2023 Category: Pharmaceuticals Source Type: news
Variants ID Outcomes in Adults With Leukemia in Relapse Prior to Stem Cell Transplant
TUESDAY, March 21, 2023 -- For patients with acute myeloid leukemia (AML) in first remission prior to allogeneic hematopoietic cell transplant, specific variants can identify patients at risk for increased relapse and worse survival, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2023 Category: Pharmaceuticals Source Type: news
Baby's mystery bruises and flu-like symptoms revealed to be leukaemia
The baby's mother said she was questioned by doctors about abusing him due to the bruises that appeared on his skin. (Source: Daily Express - Health)
Source: Daily Express - Health - March 21, 2023 Category: Consumer Health News Source Type: news
Doctors thought I was abusing my baby - his 'bruises' were actually leukaemia
Beth Reilly from Wallasey, Merseyside, first became concerned about her son Bailey Kilbane last October when he started developing strange bruises and flu-like symptoms. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2023 Category: Consumer Health News Source Type: news
Advanced Leukemia Novel Drug Leads to'Impressive' Responses Advanced Leukemia Novel Drug Leads to'Impressive' Responses
The experimental menin inhibitor revumenib led to"deep and sustained remission" for two genetic subtypes of aggressive relapsed/refractory acute leukemia in the first-in-human trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
CLL Treatment: More Infections Among Real-World Patients CLL Treatment: More Infections Among Real-World Patients
A high rate of severe infections was seen in patients with chronic lymphocytic leukemia (CLL) or B-cell lymphoma who were taking ibrutinib (Imbruvica), idelalisib (Zydelig), or venetoclax (Venclexta).MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 9, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Venetoclax Shows Promise for R/R Hairy Cell Leukemia Venetoclax Shows Promise for R/R Hairy Cell Leukemia
Five of six patients with relapsed or refractory hairy cell leukemia experienced a response to venetoclax alone or in combination with rituximab.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 9, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant
A small portion of adults in remission from a deadly blood cancer had persisting mutations that were detected, which predicted their risk of death from having the cancer return. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 7, 2023 Category: American Health Source Type: news
First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL
The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 3, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
Recent advances in cancer genomics have deepened the medical community ’s understanding of the molecular alterations in braintumours, more preciselysubclassifying patients into specific diagnoses.Understanding a patient ' sbraintumour mutation status in the IDH1 and ATRX genes enables more informed clinical decisions and may improve patient outcomes.The IDH1 R132H and ATRX antibodies are the latest additions to Roche ’s neuropathology portfolio, which contains 29 biomarkers.Basel, 23 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibo...
Source: Roche Media News - February 23, 2023 Category: Pharmaceuticals Source Type: news
Maternal Infection Linked to Increased Risk for Childhood Leukemia
WEDNESDAY, Feb. 22, 2023 -- Maternal infection, especially genital and urinary tract infections, during pregnancy are associated with an increased risk for childhood leukemia in offspring, according to a study published online Feb. 20 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2023 Category: Pharmaceuticals Source Type: news
Survival Lower for Children With Leukemia Living on Texas-Mexico Border
TUESDAY, Feb. 21, 2023 -- For children with acute lymphoblastic leukemia (ALL), but not those with acute myeloid leukemia (AML), living along the Texas-Mexico border is associated with inferior survival, according to a study published online Feb. 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2023 Category: Pharmaceuticals Source Type: news
Leukemia: Preventing Chemotherapy-Induced Vascular Toxicity Leukemia: Preventing Chemotherapy-Induced Vascular Toxicity
Tyrosine kinase inhibitors markedly improve patients ' chances of survival but also cause a rise in blood pressure that must be treated quickly.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
TUESDAY, Feb. 21, 2023 -- In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall survival and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2023 Category: Pharmaceuticals Source Type: news
